Huan Xie, Maoyuan Xiang, Dongfeng Zeng. "A single-arm, open-label trial to evaluate the efficacy and safety of reduced-dose daratumumab in combination with bortezomib and dexamethasone (DVd-lite) in patients with newly diagnosed monoclonal gammopathy of renal significance (MGRS)." Blood, 2025. doi:10.1182/blood-2025-7504